Qualitest Recalls Hydroxyzine Tablets Due to Unreadable Codes
Qualitest Pharmaceuticals is recalling specific lots of Hydroxyzine Hydrochloride Tablets, USP 25 mg because identification codes may be unreadable.
Lower-risk recall
Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable
Contact the company
What happened, in plain English
Qualitest Pharmaceuticals is recalling certain bottles of Hydroxyzine Hydrochloride Tablets, USP 25 mg because the identification codes on some tablets may be unreadable. This issue affects 100 count, 500 count, and 1000 count bottles distributed nationwide. The recall was initiated on June 29, 2015. Read more at govinfonow.com/recall/44114-qualitest-pharmaceuticals-recalls-hydroxyzine-hydrochloride-tablets-usp-25-mg-rx.
Source Summary by GovInfoNow · govinfonow.com/recall/44114-qualitest-pharmaceuticals-recalls-hydroxyzine-hydrochloride-tablets-usp-25-mg-rx · Updated October 12, 2026 · FDA enforcement record: FDA #D-1239-2015
Cite this page
“Qualitest Recalls Hydroxyzine Tablets Due to Unreadable Codes.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44114-qualitest-pharmaceuticals-recalls-hydroxyzine-hydrochloride-tablets-usp-25-mg-rx. Based on FDA recall #D-1239-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1239-2015%22&limit=1).
Why it’s dangerous
The hazard is that the identification codes printed on some of the tablets may be unreadable. This could potentially make it difficult to verify the medication's identity or expiration date, though no direct physical injury mechanism like toxicity or contamination is described in the record.
Who’s affected
Consumers who purchased specific lots of Hydroxyzine Hydrochloride Tablets, USP 25 mg from pharmacies or retailers across the United States. Individuals relying on these specific bottles for their medication are the primary group affected by this identification issue.
How to tell if you have this one
Check your bottles for the following details: Brand Qualitest Pharmaceuticals; Product Hydroxyzine Hydrochloride Tablets, USP 25 mg, Rx only. Look for NDC numbers 0603-3968-21 (100 count), 0603-3968-28 (500 count), or 0603-3968-32 (1000 count). Verify the lot numbers and expiration dates: Lot T144F13A (exp 6/15), T130G13B (exp 3/16), T132G13A (exp 6/15), T115D14A (exp 3/16) for 100 count; Lot T144F13B (exp 6/15) for 500 count; and Lots T144F13C, T132G13B (exp 6/15), T115D14B (exp 3/16) for 1000 count.
- Brand
Qualitest Pharmaceuticals- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 16 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
How many bottles are being recalled?
A total of 47,376 bottles are included in this recall.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1239-2015 (June 29, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1239-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.